Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.87 | 1.87 | 0.00 |
Shares | 98.13 | 98.13 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.56 | 23.76 |
Price to Book | 8.46 | 4.65 |
Price to Sales | 5.15 | 3.46 |
Price to Cash Flow | 19.77 | 16.64 |
Dividend Yield | 1.60 | 1.25 |
5 Years Earnings Growth | 11.28 | 13.26 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 27.14 | 16.03 |
Consumer Defensive | 25.56 | 7.33 |
Technology | 20.14 | 27.49 |
Communication Services | 11.84 | 8.45 |
Consumer Cyclical | 8.64 | 12.25 |
Financial Services | 4.49 | 13.77 |
Industrials | 2.18 | 12.01 |
Number of long holdings: 30
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.77 | 412.87 | -0.43% | |
Novo Nordisk B | DK0062498333 | 9.60 | 721.8 | -2.21% | |
Meta Platforms | US30303M1027 | 7.86 | 563.09 | -0.43% | |
L'Oreal | FR0000120321 | 5.96 | 322.90 | +0.84% | |
Stryker | US8636671013 | 5.40 | 390.14 | +1.16% | |
Philip Morris | US7181721090 | 4.55 | 131.21 | +0.63% | |
Visa A | US92826C8394 | 4.41 | 309.90 | +0.82% | |
IDEXX Labs | US45168D1046 | 3.94 | 418.55 | -0.01% | |
ADP | US0530151036 | 3.89 | 304.57 | +2.00% | |
Louis Vuitton | FR0000121014 | 3.87 | 574.90 | -0.09% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 14.07B | 7.03 | 3.20 | 14.20 | ||
Fundsmith Equity I Inc | 4.17B | 7.03 | 3.20 | 14.20 | ||
Fundsmith Equity R Inc | 15.54M | 6.50 | 2.58 | 13.50 | ||
Fundsmith Equity T Acc | 3.92B | 6.94 | 3.10 | 14.09 | ||
Fundsmith Equity T Inc | 231.81M | 6.94 | 3.10 | 14.08 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review